Journalists Critical In ART Adherence Information Dissemination
Journalists have been identified as an important vehicle in communicating and raising awareness around Antiretroviral Therapy (ART) adherence, a top government official has said. By Patricia Mashiri recently in Chinhoyi Speaking during a National AIDS Council (NAC) media workshop aimed at informing capacitating Journalists on HIV/AIDS reporting, Dr John Mangwiro, the Deputy Minister of Health
Read More
US Government Delivers 2, 1 Million Bottles Of TLD To Zim
THE United States Government through USAID’s supply chain and procurement project has delivered 2, 1 million bottles of Tenofovir-Lamivudine-Dolutegravir (TLD) to Zimbabwe. By Kudakwashe Pembere Zimbabwe transitioned to this new regimen with the Dolutegravir component in May 2018 said to have less side effects than Efavirenz. The United States Government USAID’s supply chain and procurement
Read More
Zimbos Now Buying ARVs In Zambia
PEOPLE Living With HIV have resorted to buying Antiretroviral drugs from neighboring Zambia amidst fears of developing side effects from the expired stocks currently being dispensed in some health institutions. By Kudakwashe Pembere & Michael Gwarisa This is despite the assurance from the Medicines Control Authority of Zimbabwe (MCAZ) that the medicines have been tested
Read More
Parliament Petitioned Over ARV Shortages
PEOPLE Living With HIV (PLHIV) have handed over a petition to the Parliament of Zimbabwe in a bid to push government to urgently allocate financial resources to arrest the prevailing drug shortage before the situation goes out of hand. By Michael Gwarisa The development comes at the back of indications that the National Aids Council
Read More
DTG Won’t Be Forced On Citizens- Ministry
PEOPLE Living With HIV (PLHIV) and on Antiretroviral Therapy (ART) still have the option to continue taking other ART options apart from Dolutogravir (DTG) based regimens  since the process is not compulsory, a ministry of health and child care (MoHCC) official has said. By Michael Gwarisa in Gweru Zimbabwe commenced its transition process from Tenovir/Lamuvidene/Efavirens
Read More
Zim Commences DTG Drug Transition
DEPUTY Director HIV/AIDS and STIs in the ministry of health and child care (MoHCC), Dr Tsitsi Apollo says the country has already commenced its transition process from Tenovir/Lamuvidene/Efavirens to Dolutegravir (DTG), a first line regimen of Antiretroviral Therapy (ART) which has less side effected and a rapid viral suppression. By Michael Gwarisa The whole transition
Read MoreZim Defers HIV Drug Roll Out…Drug Deforms Unborn Babies
THE Ministry of Health and Child Care (MoHCC) has deffered roll out of the HIV Dolutegravir (DTG) drug following indications that it causes complications in women of child bearing age and adolescent girls, which might lead to deformities in unborn babies born to HIV positive mothers taking the drug at the time of conception. HealthTimes
Read More